A Compendium of Clinical Research and Practice


Subscribe Current Issue Archives Continuing Education Submit an Article Contact Us
Search Articles:
Wounds Home
Current Issue
Archives
Search Articles
Subscribe to Wounds
Industry News
New Products
Classifieds
Continuing Education
Supplements
Enewsletters
Editorial Board
Contact Us
Author Instructions
Rapid Review
About Us

Bioengineered skin equivalent
Negative pressure wound therapy
Acellular dermal matrix
Diabetic neuropathy
Silver dressings
Enzymatic debridement

Autolytic debridement
Wound necrosis
Surgical debridement
Mechanical debridement
Wound fibroblasts
Delayed wound healing
Impaired wound healing
Compression stockings
Diabetic foot wounds
Pressure dressing

Bioengineered Skin Equivalent


Bioengineered skin used to treat chronic wounds, burns, and rare skin conditions. Bioengineered skin consists of a dermal layer and/or an epidermal layer, which is embedded into a cellular matrix and promotes new skin growth.  Feel free to browse through our articles below.



Supplements:

Special Publication:
The following is a collection of publications from Healthpoint intended to facilitate expeditious, cost-effective wound care management. There will be nine publications total.

Related Links:
Symposium on Advanced Wound Care (SAWC)
The Buck Stops Here
Association of Advanced Wound Care
Ostomy/Wound Management
Podiatry Today
Vascular Disease Management
Wound Healing Society

Article Submission:
All submissions for consideration should be submitted online using the Rapid Review Web-Based Review System at www.rapidreview.com. Authors should scroll down to HMP Communications and click on Author.

Two Cases of Traumatic Wounds in Patients with Ehlers-Danlos Syndrome Successfully Treated with a Bioengineered Skin Equivalent
Abstract: The authors present two cases in which traumatic wounds in patients with Ehlers-Danlos syndrome (EDS) were successfully treated with a bioengineered skin equivalent (BSE) (Apligraf®, Organogenesis, Canton, Massachusetts). Due to defects in collagen metabolism, it has been reported that patients with EDS have poor wound healing and unsightly scarring. Considering this, it is important to look into alternate ways to improve the healing process while avoiding donor site morbidity. The authors have demonstrated, in these two cases, the successful use of BSE as an option for use in the healing of wounds in patients with this syndrome.


The Use of a Biologic Tissue Matrix (Integra? Bilayer Matrix Wound Dressing) in the Treatment of Recessive Dystrophic Epidermolysis Bullosa Pseudosyndactyly Deformity
Pseudosyndactyly, a mitten deformity of the hand, is a serious problem that can arise in children with recessive dystrophic epidermolysis bullosa (EB). The authors present 2 cases of patients who developed significant contractures of their hands with limited functional use secondary to pseudosyndactyly. At the time of both initial operations, digit separation and contracture releases were performed, which resulted in large areas of denuded skin on the palmar and volar aspect of the fingers and hand. A biologic tissue matrix (Integra? Bilayer Matrix Wound Dressing, Integra Lifesciences Corp., Plainsboro, NJ) was used initially to cover the wounds. Subsequently, a bioengineered skin equivalent (Apligraf?, Organogenesis Inc., Canton, Mass) was used for epidermal coverage. The biologic tissue matrix was selected because of its excellent tensile strength, flexible adherent covering, and success with decreasing the incidence of postoperative wound contracture, which the authors believed was necessary for the hands to heal successfully. Skin grafting was not an option in either case because the patients did not have any suitable harvest sites secondary to the generalized blistering as a result of the epidermolysis bullosa. The bioengineered skin equivalent was used to promote reepithelization of the neodermis created by the biologic tissue matrix by delivering multiple growth factors and cytokines.


Editorial Message
Editorial Message Editor's Message: Editorial Message - David T. Rovee, PhD November, 2006Dear Readers, The use of silver nitrate and silver sulfadiazine (SSD) has been common in burns for many years. Yilmaz et al (Effect of low-energy gallium arsenide [GaAs, 904 nm] laser irradiation on wound healing in rat skin) report on the effects of laser irradiation on the healing of circular excisions in animals. &...


Cutaneous Manifestations of Diabetes
Abstract: Diabetes mellitus is a chronic disease of metabolic dysregulation involving the abnormal metabolism of glucose. Diabetes has a significant impact on the healthcare costs of the Western world. Nearly all patients with diabetes eventually develop cutaneous manifestations of the disease. Cutaneous signs of the disease can heighten the suspicions of a physician regarding the diagnosis of diabetes. This article will focus on the clinical features, pathogenesis, and treatment modalities of the various dermatologic manifestations of the disease ranging from the more benign granuloma annulare to the more sinister diabetic ulcer.


June 2003 Editor's Message
June 2003 Editor's Message Editor's Message: June 2003 Editor's Message - David Rovee, PhD Editor, WOUNDS Dear Readers: I welcome the addition of our new department editor, Dr. Sarah Cockbill, who heads the department on veterinary wounds. While wounds on the general body skin heal uneventfully, wounds on the lower limb of the horse often are complicated by exuberant granulation tissue (termed proud flesh), either failure to heal or slow healing, and little contraction. , (Apoptosis in skin...


© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd | Suite 100 | Malvern, PA 19355